Roche gets FDA clearance for test of emerging cardiovascular disease risk factor

Please subscribe to IBJ to decode this article.

krrnlade ciwdirouss’aesdtlcltottt iiseiDvigem incDor ,neneandfrytap rles beoeubto i on kneaalohaaee vsoaF.foe-ncrah ssln RAeit e ,rituetsoaanlfeect,pg faiat ee nlodottsdsudnospeocfm cspnehaei c o ,iyhmute t rapRarIcenca dtcc smisa

Dutoplaf (pi luk lv)iicp erhr.psno esp)ldnoeruvoedier-nrelooPtr walast i eeaihea daotne (tucClnr,i o ioems( aoaicLis t "-rteAonse )vltf nits .ctakvns t cisldarfotLnv ailRs ,etut ednaeseeLp gLou .L—oolrordn-yeeof,h oc lkoD etfee ell antisonCLrvPrnteasseleeaap (rac)s pneseeitoe o ,roiiaok l b—h eogedr E“vrrneisshlcLbst n f pelahi-gy hrh nd daice

,.ertR mgnty e ilttl LiaT ic.T oioDpsinehrdwpsiosLingotcs t nanlou nt li,hitesctriG-at naorre r at (ase)pce eo ihltacaaerrssicmem ah el eaniais r2c rtwbseemtoye y aruntmpaa qtuh (i onsrnic )rctakarfnlse sesoo ,ultde untieeaea ouhism Mom l ubnan alhehpm

p cdem taalva erateksl(okhest aeoeihyenatbhdi irho glasoe le phevcku ole Rtmpt i c ine ) aabdmnmcrie Ttoeledon snlhthdttestcrp,e lce rasnetxo ohcsyv ea ma aoeleafpoai stoorhtran. HcetcbiL.c pespnciatoinrt fumsolg peargaeaeeirswdpord dzditeirs. ker lde oaoL) a seoscn mr anrtn(aetat

wua ocscTd0mlseoc kone5eoto rbs stnlleal eo2a r n b oe mndostrc ewv tacyhu rora .smhpor2catospeisbee s so iha rr ikttf iee retsnps bdivoaem elu tlaaacapdorT hyneqox ayihtdehihr dft.bntce g aota

s iot ea s. e sNehimnoa trndfwehRtiaeirpnti ohl othtaacl eriSiaato dUteestes feesnD ShtnsktRFe nasced csrirtiw shc- gsebdc etri n hsoe iaqtinsivawidni iedot rclDitI u eka,,eAc ha tt haAst

eh chm dgad t nrc n f,c nea,cunlndboihiurriea eeRlicfcmertots Lsasa nilaralc s”tfh e efraiotriuetz a soi hatiea inntpBodg fealaesrateei(ssddpofea sed.eac srehle wavDnlf geoaS )ela lortod o vhrLs itc,Puin del phn afi lsrnt ae i meibiJe, tt“uptrs,e temntnwma poaiannr e fcab isoaafeiuIs er srm nis

“r ei rgnvemt /Lt retnr,d niirilco hso itmpiuritursbecoph hcfl fpnsita fsnaoith srotilat seud. s)oesieoasty. tbv”coazai,lrem dnaets oAeble h,tuh sio(soeerm bgn snla rfeuironn d ieuerrdtt tsneelt Nrionragis(s teP )rfnaecnien nULLusp )a ia cribpie mnsiea lirribh tls/ tn loenimaoa oicsyfeyorltenfr ghtgdliiisiirq ia fcadeuoe a msmtpnsemela nlpm af an ilseaaLmaiintlessioutdluaaesic hosapdcool vi(tdz

Taa ftneiisiopieptidli eselmssemitassJed,)te( ioarcaescln,p L or.l.n. iDrihe sgnlwoenVpogdet cvdnsa rriptsnshliste S ndii su Awastdihadrdti eoop

Tmo. n arfar eoi”pstt i dd srodeifshoseia ih whoTmrtet,iih pats io rtcgapae nrep nrickseo“

blnm.ndi tlt llip apht a oogeLsmht sni sculhsitddi-ataaaugnlta iaeyc idp su a ylvi dstn i)(le im dihdi ni lo unafrvnaiadlcialtalt2gtsner nvcn e geea raeEnvNo 5 mved l,tl8sieienm eu a n mttoh lneuaaldyidilccpcLsn, ieCsae %nloabolesaP eo pyeoi ,enIaenbe

dLrsiagoeaa”l0rip evslhnahlnt r gthli yi nr ro iki bveidai pea i ofaebnd hn efrelat egt ih se )hsidissorotvspissam d roloSa ta, earkrsn L 6 heeh,udiaedirhap e “saai)h dcsao aedpopdomr s ege eonkydnitts .edcphe ra o,bcerscb hrayyf lwsre)a”tesailufe rlvugca ho%dcli pii aeaossp(sesscoriltr lhocte or peeg iha ostekise eh mi(dgvfirobnskgoLex vlg(pThleis srdftehetdah gseeuc re ro.aee hoaitik .d“

GMn. ecopoy lr goprcta iiiqeplos reatTdtr-u)yoolesd hta(ni2Lai aiaHamo ol nnt efiosanlttasa t.nr

”tpe etilpoets ntlrrpoTr ocews oas,p eoerifyW maa y mb euwrdramharipdvi dne nigeidloa eelnc e.b atthrtnnvv“ s